Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

医学 心房颤动 肥厚性心肌病 导管消融 心脏病学 内科学 导管 烧蚀 心肌病 外科 心力衰竭
作者
Jordan M. Prutkin,David S. Owens
出处
期刊:Heart [BMJ]
卷期号:102 (19): 1513-1514 被引量:5
标识
DOI:10.1136/heartjnl-2016-309761
摘要

Atrial fibrillation (AF) is a well-recognised comorbidity in patients with hypertrophic cardiomyopathy (HCM), occurring in about 25% of patients.1 It is associated with increased mortality and worse heart failure symptoms, especially if there is concomitant outflow tract obstruction,2 and can be markedly debilitating in some individuals. The loss of atrial kick can reduce preload and worsen or unmask outflow obstruction, and higher ventricular rates can decrease cardiac outputs by reducing left ventricular (LV) filling time in the setting of diastolic dysfunction and reduced LV compliance. Rhythm control strategies are indicated with symptomatic AF, but the current antiarrhythmic choices are suboptimal. Patients with HCM have a propensity for both atrial and ventricular arrhythmias, and there is little data on the safety of antiarrhythmic therapies in this population. Disopyramide is perhaps the best studied agent and may concurrently help to mitigate outflow obstruction through its negative inotropic properties. However, its use is limited by anticholinergic effects and breakthrough AF is common. Amiodarone is more efficacious, but has well described toxicities and should be used cautiously in young individuals. Sotalol, dofetilide and dronedarone may also be considered, but there is less data supporting their use, and there must be caution in monitoring the QT interval with the first two agents and heart failure symptoms with the latter.3 ,4 In this setting, the use of an AF ablation strategy for rhythm control is quite attractive. HCM may manifest as progressive fibrosis and stiffening and any interventions that can slow AF progression would be beneficial, but evidence for the efficacy of AF ablation in HCM is also lacking. In their Heart publication, Providencia et al report a systematic review and meta-analysis of AF ablation in …
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
刚刚
1秒前
2秒前
指哪打哪完成签到,获得积分10
2秒前
2秒前
静静子发布了新的文献求助100
3秒前
Ray完成签到 ,获得积分10
4秒前
文静的天蓝完成签到,获得积分10
4秒前
tszjw168完成签到 ,获得积分10
5秒前
手打鱼丸完成签到 ,获得积分10
6秒前
体贴凌柏发布了新的文献求助10
6秒前
开心快乐发大财完成签到,获得积分10
8秒前
萌萌哒完成签到,获得积分10
8秒前
小龅牙吖完成签到,获得积分10
8秒前
Propitious完成签到,获得积分10
9秒前
徐先生1106完成签到,获得积分10
9秒前
Epiphany完成签到,获得积分10
10秒前
舒心的久完成签到 ,获得积分10
10秒前
闻巷雨完成签到 ,获得积分10
12秒前
北风完成签到,获得积分10
13秒前
xliiii完成签到,获得积分10
13秒前
时光倒流的鱼完成签到,获得积分10
14秒前
LL完成签到,获得积分10
14秒前
李李完成签到,获得积分20
14秒前
雨无意完成签到,获得积分10
15秒前
盛宇大天才完成签到,获得积分10
17秒前
游戏人间完成签到 ,获得积分10
18秒前
19秒前
科研通AI5应助淡淡的忆彤采纳,获得10
19秒前
早日毕业完成签到,获得积分10
19秒前
Billie完成签到,获得积分10
20秒前
积极行天完成签到,获得积分10
20秒前
98完成签到,获得积分10
21秒前
nkmenghan完成签到,获得积分20
22秒前
韶邑完成签到,获得积分10
22秒前
penzer完成签到 ,获得积分10
23秒前
suwan完成签到,获得积分10
24秒前
张瀚文完成签到 ,获得积分10
27秒前
不吃香菜完成签到 ,获得积分10
29秒前
何日完成签到,获得积分10
31秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029